DiGeorge Syndrome Critical Region Gene 8 (DGCR8) (N-Term) Peptide
DGCR8
Reactivity: Human
Host: Synthetic
BP, WB, IHC
-
- Target See all DGCR8 products
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-DGCR8 antibody (Catalog #: ARP40984_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
- Synonyms
- MGC78846 Peptide, DGCR8 Peptide, gy1 Peptide, dgcrk6 Peptide, C22orf12 Peptide, DGCRK6 Peptide, Gy1 Peptide, pasha Peptide, D16H22S1742E Peptide, D16H22S788E Peptide, D16Wis2 Peptide, N41 Peptide, Vo59c07 Peptide, si:ch211-106a19.4 Peptide, wu:fc23f08 Peptide, wu:fc38f06 Peptide, DGCR8 microprocessor complex subunit L homeolog Peptide, DiGeorge syndrome critical region gene 8 Peptide, DGCR8 microprocessor complex subunit Peptide, DGCR8, microprocessor complex subunit Peptide, microRNA 3618 Peptide, dgcr8.L Peptide, DGCR8 Peptide, dgcr8 Peptide, Dgcr8 Peptide, MIR3618 Peptide
- Background
-
DGCR8 contains 2 DRBM (double-stranded RNA-binding) domains and 1 WW domain. It may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
Alias Symbols: C22orf12, DGCRK6, Gy1, pasha
Protein Interaction Partner: RNASEN,RNASEN,RNASEN
Protein Size: 773 - Molecular Weight
- 85 kDa
- Gene ID
- 54487
- NCBI Accession
- NM_022720, NP_073557
- UniProt
- Q8WYQ5
-
You are here:
